Form 4: Pediatrix Medical Group Executive Sells Shares

Mary Ann E. Moore, an executive at Pediatrix Medical Group, sold 8,108 shares of common stock at an average price of $16.00 per share.

Summary

• Mary Ann E. Moore, an EVP, GC, Chief Admin Off & Sec at Pediatrix Medical Group, sold 8,108 shares of common stock on November 8, 2024.
• The shares were sold at a weighted average price of $16.00, with individual transaction prices ranging from $16.00 to $16.03.
• Following the transaction, Ms. Moore directly owns 135,810 shares and indirectly owns 15,730 shares through a trust.
• Ms. Moore and her spouse are trustees of the trust, and she disclaims beneficial interest except for her pecuniary interest.

Sentiment

Score: 5

Explanation: This is a neutral event, a routine stock sale by an executive. It doesn't indicate positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to an executive's stock sale and is common in publicly traded companies. It does not indicate any specific trend in the healthcare industry.

Comparison to Industry Standards

• Executive stock sales are a common occurrence in publicly traded companies, and this transaction is within the normal range of such activities.
• Form 4 filings are standard practice for reporting insider transactions to the SEC, ensuring transparency and compliance with regulations.
• The sale of 8,108 shares by an executive is not unusual and does not indicate any significant deviation from industry norms.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the company's overall performance or valuation.

Key Dates

Keywords

Pediatrix Medical Group, stock sale, insider trading, executive, common stock, share sale, Form 4